Abstract
Aims: Lactobacillus rhamnosus GG (L. rhamnosus GG) possess immunomodulatory effects in the host. In the present study, the effect of L. rhamnosus GG on cyclooxygenase 2 (COX2) expression and its pharmacological control was investigated in human T84 colon epithelial cells. Methods and Results: T84 cells were exposed to freeze‐dried L. rhamnosus GG in vitro, and the expression of COX2 was detected by Western blot. Conclusions: L. rhamnosus GG induced COX2 expression in a time‐ and concentration‐dependent manner in T84 cells. COX2 expression was inhibited by tyrosine kinase inhibitor genistein (100 μmol l−1), p38 mitogen‐activated protein kinase (MAP kinase) inhibitor (SB203580; 1 μmol l−1) and dexamethasone (10 μmol l−1), whereas inhibitors of p42/44 MAP kinase (PD98095; 10μmol l−1), protein kinase C (Ro 31‐8220; 1 μmol l−1) and transcription factor nuclear factor kappa B (NF‐κB) [pyrrolidinedithiocarbamate (PDTC) 100 μmol l−1] had practically no effect. Significance and Impact of the Study: The results provide novel information on the cellular mechanisms involved in the interaction between L. rhamnosus GG and colon epithelial cells.

This publication has 25 references indexed in Scilit: